Akebia Therapeutics Competitors, Revenue and Alternatives

Claim your profile

Overview

Location:
Boston, MA USA
Total Funding:$142.1M
Industry:Biotech
Founded:2007
Lead Investor(s):Morgan Stanley
Press
Claim your profile

Industry Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Akebia Therapeutics's estimated annual revenue is currently $235M per year.
  • Akebia Therapeutics received $85.0M in venture funding in March 2018.
  • Akebia Therapeutics's estimated revenue per employee is $560,859
  • Akebia Therapeutics's total funding is $142.1M.

Employee Data

  • Akebia Therapeutics has 419 Employees.
  • Akebia Therapeutics grew their employee count by 14% last year.
  • Akebia Therapeutics currently has 12 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Ultivue
$8.7M56-12%N/A
Ohana Bioscienc...
$8.7M5660%N/A
Compass Therape...
$16.4M10614%N/A
Cell Signaling ...
$89.4M577N/AN/A
Momenta Pharmac...
N/A220N/AN/A
Emulate
$15.3M99-17%N/A
ArQule
N/A94N/AN/A
Hamilton Storag...
$17.2M1119%N/A
Alnylam Pharmac...
$74.9M127731%N/A
Transgenomic
N/A47N/AN/A
Missing a competitor? Contribute!?
Submit

Akebia Therapeutics, Inc. is a growing biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on the development and commercialization of therapeutics for patients with chronic kidney disease. For more information, please visit our website at www.akebia.com.

keywords:Biotechnology,Healthcare,Pharmaceuticals

419

Number of Employees

$235M

Revenue (est)

12

Current Jobs

14%

Employee Growth %

$142.1M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Executive Contacts

NameTitleEmail
Mark RoschSenior VP, Regulatory Affairs, Quality Assurance & CMC
Steven BurkeChief Medical Officer
Lee KaukasSenior Director, Alliance Management
John ButlerPresident And Ceo
Jason AmelloSenior Vice President, Chief Financial Officer and TreasurerEmail Available
Randy BennettDirector & Chief Of Staff, Cmo Office
Susan BradyCorporate Communications ManagerEmail Available
Ute MinerProject Manager
Xiao HuDirector
Young Chun JungDirectorEmail Available

Akebia Therapeutics News

09/03/2019 - Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass.--(BUSINESS WIRE)--. Akebia Therapeutics, Inc. (AKBA), a biopharmaceutical company focused on the development and ...

09/08/2019 - Is Akebia Therapeutics, Inc. (AKBA) a great play right now?

On Tuesday, shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA) marked $4.11 per share versus a previous $4.13 closing price. With having ...

09/03/2019 - Akebia Therapeutics, Inc. (AKBA) Down -3.89%: Why This Stock Is Killing Today

Akebia Therapeutics, Inc. (NASDAQ:AKBA) is among the top losers of the stock market today, sinking -3.89% or (-0.16 points) to $3.95 from its ...

Akebia Therapeutics Funding

DateAmountRoundLead InvestorsReference
2008-12-22$15.1MAArticle
2009-07-29$16.0MUndisclosedNovartis Bioventures Ltd, Venture Investors LLCArticle
2011-04-27$22.0MUndisclosedNovartis Venture Fund, Venture Investors LLCArticle
2012-01-10$4.1MSeries BNovartis Bioventures, Venture InvestorsArticle
2013-06-05$41.0MCSatter Investment Management LArticle
2015-04-24$64.6MUndisclosedUBS Investment BankArticle
2017-07-07$67.0MUndisclosedMorgan StanleyArticle
2018-03-26$85.0MUndisclosedMorgan StanleyArticle

Akebia Therapeutics Executive Hires

DateNameTitleReference
2013-08-29John P. ButlerPresident/CEOArticle
2013-10-17Jason A AmelloSVP/CFO/TreasurerArticle
2014-01-14Nicole R. HadasVP General CounselArticle
2014-08-07Brad MaroniSVP/Chief Medical OfficerArticle
2015-09-11Teresa ComptonSVP/CSOArticle
2017-05-29Rita JainChief Medical OfficerArticle

Akebia Therapeutics Acquisitions

DateCompany NameAmountNotesReference
2018-06-29Keryx Biopharmaceuticals, IncArticle